Last news
ETFs Unlock Growth in China's Booming Tech Landscape

ETFs Unlock Growth in China's Booming Tech Landscape

GUANGZHOU, China, May 29, 2025 /PRNewswire/ -- In 2025, A-share tech-focused ETFs have continued to attract significant investor interests – the top five industry/thematic ETFs by net inflows, as of May 21, were all technology-related, collectively...

Rona Therapeutics Announces Breakthrough Data on Potential Annual Dosing RNAi Therapy RN026 Targeting Lipoprotein(a) in The National Lipid Association (NLA) Scientific Sessions 2025

Rona Therapeutics Announces Breakthrough Data on Potential Annual Dosing RNAi Therapy RN026 Targeting Lipoprotein(a) in The National Lipid Association (NLA) Scientific Sessions 2025

SHANGHAI, May 29, 2025 /PRNewswire/ -- Rona Therapeutics, a global leading RNA therapy company, today announced preclinical data for its self-developed RNA interference (RNAi) therapy RN026 at the National Lipid Association (NLA) Annual Scientific...

Neuronata-R® Stem Cell Therapy Shows Promise in ALS Phase 3 Subgroup Analysis, Moves Toward FDA Accelerated Approval

Neuronata-R® Stem Cell Therapy Shows Promise in ALS Phase 3 Subgroup Analysis, Moves Toward FDA Accelerated Approval

Meaningful efficacy observed in slow-progressor subgroup; NfL biomarker improvements support potential for accelerated regulatory pathway SEOUL, South Korea, May 29, 2025 /PRNewswire/ -- Neuronata-R®, an autologous bone marrow-derived mesenchymal...

CODIT Launches 'APEC 2025' Policy Monitoring Platform

CODIT Launches 'APEC 2025' Policy Monitoring Platform

AI-Powered Legislative Insights: CODIT's Global Evidence-Based Policy Institute strengthens policy research and strategy SEOUL, South Korea, May 29, 2025 /PRNewswire/ -- CODIT, an AI-powered leading GovTech firm, has launched a policy monitoring...

AccurEdit Therapeutics' ART001 Becomes China's First Gene Editing Therapy to Receive FDA Regenerative Medicine Advanced Therapy (RMAT) Designation

AccurEdit Therapeutics' ART001 Becomes China's First Gene Editing Therapy to Receive FDA Regenerative Medicine Advanced Therapy (RMAT) Designation

RMAT designation expected to expedite development; 72 weeks interim clinical trial data showing sustainable reduction of TTR over 90% with no significant adverse events. SUZHOU, China, May 29, 2025 /PRNewswire/ -- AccurEdit Therapeutics today...

China, ASEAN and GCC Advance Cooperative Frameworks to Strengthen Regional Supply Chain Resilience

China, ASEAN and GCC Advance Cooperative Frameworks to Strengthen Regional Supply Chain Resilience

KUALA LUMPUR, Malaysia, May 29, 2025 /PRNewswire/ -- China, the Association of Southeast Asian Nations (ASEAN) and the Gulf Cooperation Council (GCC) are ramping up efforts to enhance regional economic cooperation and stabilize industrial and supply...

tHIS ASEAN 2025 to Debut in Kuala Lumpur, Uniting Southeast Asia's Healthcare Powerhouses

tHIS ASEAN 2025 to Debut in Kuala Lumpur, Uniting Southeast Asia's Healthcare Powerhouses

KUALA LUMPUR, Malaysia, May 29, 2025 /PRNewswire/ -- The Health Industry Series - ASEAN (tHIS ASEAN 2025), a groundbreaking event aimed at integrating healthcare resources across Southeast Asia, is set to take place in Kuala Lumpur during June 9-11....

Acclaro Medical Raises $23 Million in Series B Funding Led by Accelmed Partners to Advance Groundbreaking 2910 nm Fiber Laser Technology

Acclaro Medical Raises $23 Million in Series B Funding Led by Accelmed Partners to Advance Groundbreaking 2910 nm Fiber Laser Technology

Accelmed $20 Million Investment with 3E Bioventures Capital Funding of $3 Million to Drive Innovation, Clinical Expansion, and Global Market Growth SMITHFIELD, R.I., May 29, 2025 /PRNewswire/ -- Acclaro Medical, a pioneering medical technology...

1 ... 12 13 14 15 16 17 18 19 20 ... 2666
menu
menu